Skip to main content

Bariatric Surgery Linked to Reduced Incidence of Hematologic Cancer

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Sept. 27, 2023 -- Bariatric surgery is associated with reduced incidence of hematological cancer, especially for women, according to a study published online Sept. 13 in The Lancet Healthy Longevity.

Kajsa Sjöholm, Ph.D., from the University of Gothenburg in Sweden, and colleagues examined the association between bariatric surgery and hematological cancer in the Swedish Obesity Subjects study, which was designed to compare mortality in 2,007 participants undergoing bariatric surgery and 2,040 undergoing usual care. Age 37 to 60 years and a body mass index of 34 kg/m2 or more in men and 38 kg/m2 or more in women before or at the time of examination were the inclusion criteria.

The researchers found that during follow-up, 34 and 51 participants in the surgery and usual care groups, respectively, were diagnosed with hematological cancer (hazard ratio, 0.60). Three and 13 deaths from hematological cancer occurred in the surgery and control groups, respectively (hazard ratio, 0.22). A reduced incidence of lymphoma was also seen in association with surgery (hazard ratio, 0.45). The treatment effect differed between men and women, with a reduced incidence of hematological cancer seen in association with bariatric surgery among women, but not men.

"Bariatric surgery should be considered as a primary prevention resource for people with obesity," the authors write. "Future research might indicate whether cancer prevention is also obtained by the recently developed anti-obesity drugs."

One author disclosed financial ties to AstraZeneca.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral Neuropathy

FRIDAY, June 7, 2024 -- Germline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel...

Overweight in Teens, Young Adults Tied to Cerebrovascular Disease in Women

THURSDAY, June 6, 2024 -- Being overweight in adolescence or early adulthood is associated with an increased risk for cerebrovascular disease among women, according to a study...

Study Looks at Links Between Cognition, Psychopathology, Weight in Preteens

WEDNESDAY, June 5, 2024 -- Lower cognition and greater psychopathology at baseline are associated with increased weight gain for children entering adolescence, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.